Kon OL

Integrated Multimodal Evaluation of Genotoxicity in ZFN-Modified Primary Human Cells

Iatrogenic adverse events in clinical trials of retroviral vector-mediated gene-corrected cells have prioritized the urgent need for more comprehensive and stringent assessment of potentially genotoxic off-target alterations and the biosafety of cells intended for therapeutic applications.